Biopharmaceutics and pharmacokinetics of 5-phenyl-1,2-dithiole-3-thione complexed with sulfobutyl ether-7-β-cyclodextrin in rabbits

Journal of Pharmaceutical Sciences

Volumn 88, Issue 10, 1999, Pages 1016-1020

  Lefeuvre, Claudia ^a   Le Corre, Pascal ^a   Dollo, Gilles ^a   Chevanne, François ^a   Burgot, Jean Louis ^a   Le Verge, Roger ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5 PHENYL 1,2 DITHIOL 3 THIONE; ANTIOXIDANT; CYCLODEXTRIN DERIVATIVE; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; ARTICLE; CELL CULTURE; COMPLEX FORMATION; DRUG FORMULATION; DRUG METABOLISM; DRUG STRUCTURE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CLEARANCE; ORAL DRUG ADMINISTRATION; PLASMA CLEARANCE; RABBIT;

EID: 0032884813     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js9900248     Document Type: Article

References (23)

1. Jirousek, L.; Starka, L. Über das vorkommen von trithionen (1,2-dithiocyclopent-4-en-3thione) brassicapflanzen. Die Naturwissen. 1958, 45, 386-387.
2. Wattenberg, L. W. Chemoprevention of cancer. Cancer Res. 1985, 45, 1-8.
3. Steinmetz, K. A.; Potter, J. D., Vegetables, fruit, and cancer prevention: a review. J. Am. Diet. Assoc. 1996, 96, 1027-1039.
4. Ansher, S. S.; Dolan, P.; Bueding, E. Biochemicals effects of Dithiolthiones. Food Chem. Toxicol. 1986, 24, (5), 405-415.
5. Benson, A. B., III. Oltipraz: a laboratory and clinical review. J. Cell. Biochem. 1993, Suppl. 17F, 278-291.
6. Kensler, T. W.; Egner, P. A.; Trush, M. A.; Modification of aflatoxin B1 binding to DNA in vivo in rats fed phenolic antioxidants, ethoxyquin and a dithiolethione. Carcinogenesis 1985, 6, 759-763.
7. Steele, V. C.; Moon, R. C.; Lubet, R. A.; Grubbs, C. J.; Reddy, B. S.; Wargovich, M.; McCormick, D. L.; Pereira, M. A.; Crowell, J. A.; Bagheri, D.; Sigman, C. C.; Boone, C. W.; Kelloff, G. J. Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: methods and results from the NCI chemoprevention drug development program. J. Cell. Biochem. 1994, 20, 32-54.
8. Burgot, J. L.; Martin, C.; Bertrand, H. O.; Warnet, J. M.; Christen, M. O. Structure-antilipoperoxidative activity relationship in the 1,2-dithiole-3-thione series. International Symposium on Natural Antioxidants: Molecular mechanisms and health effects. Pekin, June 1995.
9. European Patent 0 641 792 A1, 1995, Mitsui Toatsu Chemicals Inc.
10. Bueding, E.; Dolan, P.; Leroy, J. P. The antishistosomal activity of Oltipraz. Res. Commun. Chem. Pathol. Pharmacol. 1982, 37, 293-303.
11. 14C-oltipraz in animals. Drug Res. 1985, 9, 1431-1436.
12. Dimitrov, N. V.; Bennett, J. L.; McMillan, J.; Perloff, M.; Leece, C. M.; Malone, W. Clinical pharmacology studies of Oltipraz - a potential chemopreventive agent. Invest. New Drugs 1992, 10, 289-298.
13. Gupta, E.; Olopade, O. I.; Ratain, M. J.; Mick, R.; Baker, T. M.; Berezin, F. K.; Benson, A. B., III; Dolan, M. E. Pharmacokinetics and pharmacodynamics of Oltipraz as a chemopreventive agent. Clin. Cancer Res. 1995, 1, 1133-1138.
14. Bieder, A.; Decouveleare, B.; Caillard, C.; Depaire, H.; Heusse, D.; Ledoux, C.; Lemar, M.; Leroy, J. P.; Raynaud, L.; Snozzi, C.; Gregoire, J. Comparison of the metabolism of oltipraz in the mouse, rat and monkey and in man. Drug Res. 1983, 33, 1289-1297.
15. Bona, M.; Boudeville, P.; Zekri, O.; Christen, M. O.; Burgot, J. L. Water/n-octanol partition coefficients of 1,2-dithiole-3-thiones. J. Pharm. Sci. 1995, 84, 1107-1112.
16. Dollo, G.; Le Corre, P.; Chollet, M.; Chevanne, F.; Bertault, M.; Burgot, J. L.; Le Verge, R. J. Pharm. Sci., in press.
17. Thuillier, A.; Vialle, J. Composés organiques soufrés. I. Sur une nouvelle méthode de préparation des aryl-5-dithiole-1,2-thiones-3. Bull. Soc. Chim. Fr. 1959, 1298-1501.
18. Hinderling, P. H. Red blood cells: a neglected compartment in pharmacokinetics and pharmacodynamics. Pharmacol. Rev. 1997, 49, 279-295.
19. Boxenbaum H. G.; Riegelman, S.; Elashoff, R. M. Statistical estimation in pharmacokinetics. J. Pharmacokinet. Biopharm. 1974, 2, 123-148.
20. Cossum, P. A. Role of the red blood cell in drug metabolism. Biopharm. Drug Dispos. 1988, 9, 321-336.
21. Neutze, J. M.; Wyler, F.; Rudolph, A. M. Use of radioactive microspheres to assess distribution of cardiac output in rabbits. Am. J. Physiol. 1968, 215, 486-495.
22. Rajesky, R. A., Stella, V. L. Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. J. Pharm. Sci. 1996, 85, 1142-1169.
23. Isacsson, G.; Singer, P. Studies on the whole-body distribution of 14C-trithioparamethoxyphenylpropene in mice. Scand. J. Dent. Res. 1985, 93, 249-252.